Asterias Biotherapeutics Announces Distribution Date Of Biotime Warrants And Conversion Date Of Series B Common Stock Into Series A Common Stock

MENLO PARK, Calif.--(BUSINESS WIRE)--Asterias Biotherapeutics, Inc. (OTCBB: ASTY) announced today that on October 1, 2014 the company will distribute 8,000,000 warrants to purchase common shares of BioTime, Inc. (the “BioTime Warrants”) at a purchase price of $5.00 per common share to holders of record on September 15, 2014 of its Series A common stock. Asterias Series A common stock will trade on an ex-dividend basis without the BioTime Warrants commencing October 2, 2014 on the OTC Bulletin Board. The BioTime Warrants have been approved for listing on the NYSE MKT under the symbol BTX WS. The BioTime Warrants will trade on a when-issued basis for one day only on October 1, 2014; beginning on October 2nd, the BioTime Warrants will trade regular way. BioTime common shares trade on the NYSE MKT under the symbol BTX.

Help employers find you! Check out all the jobs and post your resume.